Barclays Remains a Sell on Allstate (ALL)
π Barclays analyst Alex Scott maintains a Sell rating on Allstate (ALL) with a price target of $208.00.
π Scott focuses on the Financial sector, including stocks like Prudential and Arthur J Gallagher & Co.
π His track record shows a 4.5% average return and a 47.04% success rate on recommended stocks.
β The analyst consensus for Allstate is Moderate Buy with a higher price target of $239.00.
π° In the most recent quarter, Allstate reported revenue of $16.59 billion and net profit of $3.83 billion.
π This represents growth from the previous year's revenue of $16.34 billion and profit of $1.93 billion.
β οΈ The article includes various other headlines regarding Allstate, including a downgrade at Goldman Sachs.
π Other related updates mention price target adjustments by Mizuho and catastrophe loss reports.
π This content is sourced from third-party materials and has not been reviewed or endorsed by the publication.
- The company demonstrated substantial improvement in profitability, with net profit increasing from $1.93 billion last year to $3.83 billion in the most recent quarter ending December 31.
- Barclays maintains a Sell rating on Allstate with a price target of $208.00, significantly below the analyst consensus target of $239.00.
- Mizuho previously lowered its price target from $281 to $265, indicating ongoing concern among analysts regarding the stock's valuation.
- Allstate downgraded to Neutral from Buy at Goldman Sachs, showing a divergence in investor sentiment despite reported earnings growth.
- The company reported January catastrophe losses of $140M, which may impact future reserve calculations and profitability.